
Seeking Long-Term Pain Relief from a Drug-Free Injection
About this episode
The search for non-opioid pain relievers opioids has focused on pharmaceutical alternatives including non-steroidal anti-inflammatories, antidepressants, and anticonvulsants. Brixton Biosciences is developing Neural Ice, an injectable frozen slurry that can degenerate nerves in targeted areas and provide pain relief for extended periods. The discovery capitalizes on unexpected findings about the effects of a fat-reducing cosmetic procedure. We spoke to Sameer Sabir, co-founder and CEO of Brixton Biosciences, about the unmet need for pain management, how Neural Ice works, and the company’s initial focus on osteoarthritis and post-operative knee pain.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Bio Report

Resetting Severe Allergies at Their Cellular Source
The Bio Report

Innovating ADCs with Dual Targeting and Smarter Delivery
The Bio Report

Targeting the Brain’s Immune System in Alzheimer’s Disease
The Bio Report

How Gilead Is Building Durable Oncology and Immunology Franchises
The Bio Report